Overview
Lobbying Costs
37,500€
Financial year: Jan 2015 - Dec 2015
Lobbyists (Full time equivalent)
1.5 Fte (5)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
The Health Policy Partnership (HPP)
EU Transparency Register
223430420230-66 First registered on 08 Jan 2016
Goals / Remit
We are a specialist health policy consultancy.
We create innovative policy initiatives and powerful evidence–based communications for organisations across the health spectrum. We provide a unique, seamless approach to help resolve the most complex issues facing our health care systems.
We do this through rigorous research and expert synthesis of evidence, inter-sectoral collaboration, and powerful communications that act as the starting point for meaningful changes in policy and practice.Main EU files targeted
Currently no formal involvement, role, or interaction with any EU initiative, policy or legislative file, however this is possible in future (see below) and will be updated as and when any such involvement or interaction is confirmed in our work plans.
We do work with several MEPs who have donated their time for free to support (and act as Members of) the Heart Failure Policy Network (HFPN). See www.hfpolicynetwork.eu.
HPP acts as Secretariat for the HF Policy Network, a multidisciplinary group of politicians from across Europe working with patients, health professionals and other stakeholders to lead significant policy changes that may improve the lives of people with heart failure (HF).
Formal engagement with EU institutions in 2016/17 is in our mission statement, and is under discussion with members. The exact format and scope of any such plans will confirmed here in the Register as soon as plans are formalised.Address
Head Office
The Health Policy Partnership
68-69 St Martin's Lane
London WC2N 4JS
UNITED KINGDOM -
People
Total lobbyists declared
5
Employment time Lobbyists 50% 1 25% 4 Lobbyists (Full time equivalent)
1.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Time provided above relates to HPP staff time dedicated to any formal engagement with MEPs, EU officials, or where there is policy activity directly involving or targeting EU institutions - i.e. it excludes general health policy activities where other audiences are our primary targets (e.g. national policy makers, academic experts, clinicians, health providers etc), and global activities.
Person in charge of EU relations
Ms Suzanne Wait (Director)
Person with legal responsibility
Ms Suzanne Wait (Director)
-
Categories
Category
I - Professional consultancies/law firms/self-employed consultants
Subcategory
Professional consultancies
-
Networking
Affiliation
Heart Failure Policy Network - www.hfpolicynetwork.eu
(provide secretariat and lead project)
Knowledge partner for European Cancer Patients Coalition (www.ecpc.org) and the Coalition to Eradicate Viral Hepatitis from Asia Pacific (www.cevhap.org)
Member of CEVHAP (www.cevhap.org)
Expert member of the European Institute for Women's Health (www.eurohealth.ie)Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2015 - Dec 2015
Lobbying costs for closed financial year
37,500€
Other financial info
Some of the funding declared above was received as consultancy fees, whereas funding for the role of the Health Policy Partnership as secretariat for the Heart Failure Policy Network was in the form of a grant from Novartis Pharma and St Jude Medical.
Declared lobby clients
Client Name Amount Bristol Myers Squibb 10,000€ - 24,999€ European Brain Council 10,000€ - 24,999€ European Cancer Patients Coalition 10,000€ - 24,999€ Novartis Pharma AG 50,000€ - 99,999€ St Jude Medical 10,000€ - 24,999€ -
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Other activities
For clarity we mention here previous (i.e. lapsed) projects or parallel workstreams in the health policy sphere that are of note, or do not involve any formal engagement or activity with EU institutions.
1. Development of the Immuno-Oncology Action Framework with the Expert Group on Immuno-Oncology, in partnership with the European Cancer Patients Coalition , with MEP involvement - see www.healthpolicypartnership.com/io
2. Collaboration with European Cancer Patients Coalition to build an information portal on cancer immunotherapy - http://iop.ecpc.org/
3. International environmental scan on person-centred care, in partnership with the Health Foundation - http://www.healthpolicypartnership.com/example-work/person-centred-care/
4. Development of a policy atlas on the prevention of AF-related stroke - www.healthpolicypartnership.com/af
5. Launch of a Policy Toolkit on Diabetes in partnership with International Diabetes Federation Europe - www.healthpolicypartnership.com/expand
6. Facilitation of policy workshops on viral hepatitis in partnership with the Coalition to Eradicate Viral Hepatitis from Asia Pacific (CEVHAP) as well as other hepatitis multistakeholder platforms, leading to several publications
7. Other publications and policy analysis on different health topics, see: www.healthpolicypartnership.com/publications
Meetings
Meetings
None declared